Leiomyosarcoma clinical trials

Explore recruiting leiomyosarcoma clinical trials.

Recruiting leiomyosarcoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leiomyosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination with Doxorubicin versus Doxorubicin Alone as First-line Treatment in Patients with Metastatic Leiomyosarcoma (SaLuDo)

Italy, France, Spain, Belgium, Austria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATA129-EBV-205 An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (EBVision)

Spain, Belgium, Austria, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adult Participants With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas - (THE INVINCIBLE-3 TRIAL)

Spain, France, Poland, Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

L-UteCIN : Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC-1809-STBSG: A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with High Risk RetroPeritoneal Sarcoma (STRASS 2)

Denmark, Germany, Czechia, Spain, Italy, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Leiomyosarcoma trials by city

Leiomyosarcoma in Toronto Leiomyosarcoma in Vancouver Leiomyosarcoma in Montreal Leiomyosarcoma in Calgary Leiomyosarcoma in Edmonton Leiomyosarcoma in Ottawa Leiomyosarcoma in Winnipeg Leiomyosarcoma in Quebec City Leiomyosarcoma in Hamilton Leiomyosarcoma in Kitchener Leiomyosarcoma in London Leiomyosarcoma in Halifax Leiomyosarcoma in New York Leiomyosarcoma in Los Angeles Leiomyosarcoma in Chicago Leiomyosarcoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease